Ftse Mib
34.636,64
0,51%
DAX
18.752,61
0,38%
S&P 500
5.307,01
0,00%
NASDAQ
16.801,54
0,00%
Bitcoin
69.728,75
0,91%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Ayala Pharmaceuticals Inc (PK) (ADXS) Ayala Pharmaceuticals Inc (PK) (ADXS) Notizie

ADXS

Ayala Pharmaceuticals (PK) (ADXS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ADXS
DataOraFonteTitoloSimboloCompagnia
06/03/202413:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202422:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
05/03/202414:16Edgar (US Regulatory)Form DEFM14C - Definitive information statement relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/02/202423:22Edgar (US Regulatory)Form PREM14C - Preliminary information statements relating to merger or acquisitionUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
14/02/202422:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/02/202417:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/01/202422:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
20/11/202315:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/11/202322:04Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/11/202322:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
03/11/202316:46Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
02/11/202321:05Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
29/09/202312:13Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]USOTC:ADXSAyala Pharmaceuticals Inc (PK)
11/09/202318:38Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipUSOTC:ADXSAyala Pharmaceuticals Inc (PK)
23/05/202319:11Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
15/05/202322:11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
07/04/202323:21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
06/04/202323:24Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
10/02/202312:08Edgar (US Regulatory)Annual Report (10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
08/02/202323:20Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202322:52Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
30/01/202312:38Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
24/01/202300:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/01/202322:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202212:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/12/202212:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/12/202222:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
13/06/202212:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
12/05/202222:55Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
28/03/202214:57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:ADXSAyala Pharmaceuticals Inc (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:ADXS

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
TIT
Telecom Italia
BIT
TITR
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
STMMI
ST Microelectronics
BIT
ENEL
Enel
BIT
WBD
WeBuild
BIT
SPM
Saipem
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
RACE
Ferrari NV
BIT
PRY
Prysmian
BIT
SRG
Snam
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network